Introduction/Purpose The eShunt Implant (CereVasc, Inc., Boston, MA, USA) is a novel endovascular cerebrospinal fluid (CSF) shunt developed for the treatment of communicating hydrocephalus. The ...

Introduction Chronic subdural hematoma (cSDH) is a frequently encountered neurosurgical condition with an anticipated increase in prevalence due to the aging population. Middle meningeal artery ...

Introduction The safety and feasibility of intravenous cangrelor use for neuroendovascular procedures needs to be investigated. Aim of Study To investigate safety and feasibility of intravenous ...

Background Patients with end-stage renal disease (ESRD) are often excluded from clinical trials of endovascular thrombectomy (EVT). This study investigated the outcome in these patients. Methods From ...

Results A total of 70 patients underwent LVIS D assisted UIA treatment (male:female =28:50, median age 58.5 years (IQR 49–66). Among them, nearly 64.1% patients underwent SAC with a median of one LVIS ...